{"id":"NCT02595073","sponsor":"Sun Pharmaceutical Industries, Inc.","briefTitle":"Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Moderate to Severe Atopic Dermatitis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-04","primaryCompletion":"2017-01-17","completion":"2017-08-29","firstPosted":"2015-11-03","resultsPosted":"2018-12-07","lastUpdate":"2018-12-07"},"enrollment":124,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis"],"interventions":[{"type":"DRUG","name":"DSXS","otherNames":["Active"]},{"type":"DRUG","name":"Placebo","otherNames":["vehicle"]}],"arms":[{"label":"DSXS topical product","type":"EXPERIMENTAL"},{"label":"Placebo topical product","type":"PLACEBO_COMPARATOR"}],"summary":"Efficacy and Safety of DSXS (Taro Pharmaceuticals, U.S.A., Inc.) in Patients with Moderate to Severe Atopic Dermatitis","primaryOutcome":{"measure":"The Number of Patients in Each Treatment Group That Have Clinical Success","timeFrame":"28 days","effectByArm":[{"arm":"DSXS Topical Product","deltaMin":21,"sd":null},{"arm":"Placebo Topical Product","deltaMin":27,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.3353"}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":61},"commonTop":["Nasopharyngitis","Headache","Diarrhoea","Application site pain","Oral herpes"]}}